scholarly journals Development of a standardized, reproducible screening examination for assessment of pelvic floor myofascial pain

2019 ◽  
Vol 220 (3) ◽  
pp. 255.e1-255.e9 ◽  
Author(s):  
Melanie R. Meister ◽  
Siobhan Sutcliffe ◽  
Chiara Ghetti ◽  
Christine M. Chu ◽  
Theresa Spitznagle ◽  
...  
2019 ◽  
Vol 74 (6) ◽  
pp. 338
Author(s):  
Melanie R. Meister ◽  
Siobhan Sutcliffe ◽  
Chiara Ghetti ◽  
Christine M. Chu ◽  
Theresa Spitznagle ◽  
...  

2022 ◽  
Vol 19 (1) ◽  
pp. 98-105
Author(s):  
Claudia Pignatti Frederice ◽  
Ticiana Aparecida Alves de Mira ◽  
Helymar Costa Machado ◽  
Luiz Gustavo Oliveira Brito ◽  
Cássia R.T. Juliato

2019 ◽  
Vol 145 (2) ◽  
pp. 205-211 ◽  
Author(s):  
Birte J. Wolff ◽  
Cara J. Joyce ◽  
Cynthia A. Brincat ◽  
Elizabeth R. Mueller ◽  
Colleen M. Fitzgerald

2021 ◽  
Author(s):  
Wan-Ru Yu ◽  
Fei-Chi Chuang ◽  
Wei-Chuan Chang ◽  
Hann-Chorng Kuo

Abstract IntroductionIn patients with interstitial cystitis or bladder pain syndrome (IC/BPS), 85% were found to have pelvic floor myofascial pain (PFMP) and hypertonicity (PFH). However, they are not typically trained to consider or assess PFMP as a contributing factor to patients’ IC/BPS symptoms. This study aimed to explore the relationship between PFMP and treatment outcomes in women with IC/BPS.MethodsPatients with IC/BPS who received any type of treatment were prospectively enrolled. They underwent vaginal digital examination at baseline. PFMP severity was quantified on the visual analog scale (VAS). Subject assessment items included O’Leary-Sant symptom score (OSS), Global Response Assessment (GRA), and Beck’s anxiety inventory. Object assessment items included bladder computed tomography (CT), urodynamic parameters, maximum bladder capacity, and grade of glomerulation.ResultsA total of 65 women with IC/BPS (mean age, 57.1 ± 11.3 years) were enrolled in the study. Patients with more severe PFMP had significantly higher rate of dyspareunia (p = .031); more comorbidities (p = .010); higher number of PFMP sites (p < .001); and higher OSS (p = .012). PFMP severity was not significantly correlated with bladder conditions, whether subjective or objective. Moreover, PFMP severity (VAS) was significantly negatively associated with GRA score.ConclusionPFMP might affect the subjective results of IC/BPS treatment but not the bladder condition. Therefore, in the future treatment of patients with IC/BPS, digital vaginal examinations of pelvic floor muscles should be performed and focused more on the PFM-related conditions, and necessary PFM treatments, such as the vaginal pelvic floor muscle message, should be scheduled.


2019 ◽  
Vol 221 (3) ◽  
pp. 235.e1-235.e15 ◽  
Author(s):  
Melanie R. Meister ◽  
Siobhan Sutcliffe ◽  
Asante Badu ◽  
Chiara Ghetti ◽  
Jerry L. Lowder

2019 ◽  
Vol 99 (7) ◽  
pp. 946-952 ◽  
Author(s):  
Frank Aguirre ◽  
Jessica Heft ◽  
Amanda Yunker

Abstract Background Patients with pelvic pain due to pelvic floor myofascial pain syndrome are often referred for pelvic floor physical therapy, the primary treatment option. However, many patients do not adhere to the treatment. Objective The purpose of this study was to examine the adherence rate and outcomes of patients referred for physical therapy for pelvic floor myofascial pain syndrome and identify risk factors associated with nonadherence. Design This was a retrospective cohort study. Methods ICD-9 codes were used to identify a cohort of patients with pelvic floor myofascial pain syndrome during a 2-year time period within a single provider's clinical practice. Medical records were abstracted to obtain information on referral to physical therapy, associated comorbidities and demographics, and clinical outcomes. “Primary outcomes” was defined as attendance of at least 1 visit. Secondary outcomes included attendance of at least 6 physical therapist visits and overall improvement in pain. Statistical analysis was performed using chi-square, Fisher exact, and independent t tests. Nonparametric comparisons were performed using Wilcoxon signed rank test. Multivariate analysis was completed to adjust for confounders. Results Of the 205 patients, 140 (68%) attended at least 1 session with physical therapy. At least 6 visits were attended by 68 (33%) patients. Factors associated with poor adherence included parity and a preexisting psychiatric diagnosis. The odds of attending at least 1 visit were 0.75 (95% confidence interval = 0.62–0.90) and 0.44 (95% confidence interval = 0.21–0.90), respectively. Patients who attended ≥ 6 visits were more likely to have private insurance (78%) and travel shorter distances to a therapist (mean = 16 miles vs 22). Patients with an improvement in pain (compared with those who were unchanged) attended an average of 3 extra physical therapist visits (mean = 6.9 vs 3.1). Limitations Limitations include reliance on medical records for data integrity; a patient population derived from a single clinic, reducing the generalizability of the results; the age of the data (2010–2012); and the likely interrelatedness of many of the variables. It is possible that maternal parity and psychiatric diagnoses are partial surrogates for social, logistic, or economic constraints and patient confidence. Conclusions Initial adherence to pelvic floor physical therapy was less likely for multiparous women and women with a history of psychiatric diagnosis. Persistent adherence was more likely with private insurance or if the physical therapist location was closer. Pain improvement correlated with increased number of physical therapist sessions.


Sign in / Sign up

Export Citation Format

Share Document